Peptomyc
Peptomyc is a company focused on the development of a new generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research on Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.
7-day free trial · no credit card
Verified contacts
15
available on Kipplo
LinkedIn employees
22
11 to 50 range
Open roles
—
no listings
Distinct roles
13
indexed titles
Tech stack
0
tools in use
Monthly traffic
25
organic / mo
Sign up free to see all 15 verified contacts at Peptomyc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
15 contacts with verified email or phone · masked until revealed.
- HT
Hugo Thabussot
Protein Scientist · Science
EmailPhone - AT
Aatir Tungekar
Protein Scientist Process Development Cmc Cancer Therapeutics · Other
EmailPhone - LS
Laura Soucek
' () · Other
EmailPhone - MD
Manuela Dr. Med Niewel
Chief Medical Officer · Healthcare & Human Services
EmailPhone
Showing 4 of 15 verified contacts
Top roles at Peptomyc
13 distinct titles indexed · top 10 shown.
- 1' ()
- 1associate professor
- 1bioinformatician
- 1chief medical officer
- 1clinical distribution and logistics manager
- 1clinical project lead
- 1cmc project manager
- 1executive assistant
- 1lab manager
- 1preclinical project coordinator
- +3more titles
Sign up to unlock all 15 contacts at Peptomyc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 15 verified contacts at Peptomyc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.